Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009

There are approximately 44,000 cases of human papillomavirus–associated (HPV-associated) cancer each year in the United States, most commonly caused by HPV types 16 and 18. Prophylactic vaccines successfully prevent healthy people from acquiring HPV infections via HPV-specific antibodies. In order t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JCI Insight
Main Authors: Pellom, Samuel T., Smalley Rumfield, Claire, Morillon, Y. Maurice, Roller, Nicholas, Poppe, Lisa K., Brough, Douglas E., Sabzevari, Helen, Schlom, Jeffrey, Jochems, Caroline
Format: Artigo
Jezik:Inglês
Izdano: American Society for Clinical Investigation 2021
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119209/
https://ncbi.nlm.nih.gov/pubmed/33651712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.141912
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki